Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 3/20 | 0.77 |
| ▸ | MMP3 | P08254 | 2/20 | 0.77 |
| ▸ | CTSD | P07339 | 5/20 | 0.68 |
| ▸ | NAT1 | P18440 | 2/20 | 0.68 |
| ▸ | ADAMTS5 | Q9UNA0 | 3/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7971966 | 1.00 | MMP13 (0.77) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL7969145 | 0.88 | MMP13 (0.76) | MMP13MMP3CTSDADAMTS5POLB | |
| SCHEMBL4055509 | 0.88 | MMP13 (0.76) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL7969148 | 0.88 | MMP13 (0.76) | MMP13MMP3CTSDADAMTS5POLB | |
| SCHEMBL4055508 | 0.88 | MMP13 (0.76) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL10050563 | 0.87 | MMP13 (0.74) | MMP13MMP3CTSDADAMTS5POLB | |
| SCHEMBL12892045 | 0.87 | MMP13 (1.00) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL1248973 | 0.87 | MMP13 (1.00) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL1248974 | 0.87 | MMP13 (1.00) | MMP13MMP3CTSDNAT1ADAMTS5 | |
| SCHEMBL7975010 | 0.87 | MMP13 (0.81) | MMP13MMP3CTSDNAT1ADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6251928-B1 | ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| EP-0677517-A1 | Treatment of Alzheimer's disease employing inhibitors of cathepsin D | ELI LILLY AND COMPANY (US) | 1995-10-18 | — | — | EP | disclosed |